| RS2120577091 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome, Kabuki syndrome 1 |
| RS2120580820 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120590311 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120599595 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120605276 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120606244 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120606259 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120612017 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120620126 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS2120621151 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120621215 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS2120621227 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120631929 |
PTHLH
|
Health Risk |
Pathogenic |
— |
| RS2120632521 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120632541 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120632984 |
PTHLH
|
Health Risk |
Pathogenic |
— |
| RS2120647463 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120648164 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120649411 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120650961 |
PTPRQ
|
Health Risk |
Pathogenic |
— |
| RS2120651305 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS2120654180 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Inborn genetic diseases |
| RS2120657018 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120663922 |
KMT2D
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2120670890 |
PTHLH
|
Health Risk |
Pathogenic |
Brachydactyly type E2, Brachydactyly type E2 |
| RS2120671121 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS2120671676 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS2120682681 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120685231 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120689175 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS2120691810 |
ACVR1B
|
Health Risk |
Pathogenic |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS2120692230 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS2120692527 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS2120693175 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120694782 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120696377 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, KMT2D-related disorder |
| RS2120702721 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120707119 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120707151 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120711101 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120712071 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120713201 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS2120713766 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS2120713788 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 1, Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome |
| RS2120807666 |
HMGA2
|
Health Risk |
Pathogenic |
Silver-Russell syndrome 5, Silver-Russell syndrome 5 |
| RS2120818344 |
CNTN1
|
Health Risk |
Likely pathogenic |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS2120819481 |
CNTN1
|
Health Risk |
Pathogenic |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS2120821285 |
DHH
|
Health Risk |
Pathogenic |
46, XY sex reversal 7 |
| RS2120831286 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS2120845441 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS2120850531 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS2120852980 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS2120862502 |
JAM3
|
Health Risk |
Likely pathogenic |
Porencephaly-microcephaly-bilateral congenital cataract syndrome, Porencephaly-microcephaly-bilateral congenital cataract syndrome |
| RS2120893783 |
NCKAP1L
|
Health Risk |
Pathogenic |
Immunodeficiency 72 with autoinflammation, Immunodeficiency 72 with autoinflammation |
| RS2120939967 |
KRT2
|
Health Risk |
Likely pathogenic |
— |
| RS2121000699 |
KRT1
|
Health Risk |
Pathogenic |
Epidermolytic hyperkeratosis 1, Epidermolytic hyperkeratosis 1 |
| RS2121004044 |
KRT1
|
Health Risk |
Likely pathogenic |
— |
| RS2121007459 |
KRT1
|
Health Risk |
Likely pathogenic |
— |
| RS2121008110 |
KRT1
|
Health Risk |
Likely pathogenic |
— |
| RS2121080959 |
AAAS
|
Health Risk |
Pathogenic |
— |
| RS2121081165 |
AAAS
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS2121081890 |
AAAS
|
Health Risk |
Pathogenic |
— |
| RS2121082201 |
AAAS
|
Health Risk |
Pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS2121089586 |
AAAS
|
Health Risk |
Likely pathogenic |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS2121089867 |
AAAS
|
Health Risk |
Pathogenic |
— |
| RS2121153865 |
TBX3
|
Health Risk |
Likely pathogenic |
Ulnar-mammary syndrome, Ulnar-mammary syndrome |
| RS2121158390 |
TBX3
|
Health Risk |
Likely pathogenic |
Ulnar-mammary syndrome, Ulnar-mammary syndrome |
| RS2121217835 |
KRT3
|
Health Risk |
Likely pathogenic |
Corneal dystrophy, Meesmann |
| RS2121223982 |
PTPRQ
|
Health Risk |
Pathogenic |
Hearing loss, autosomal dominant 73 |
| RS2121241118 |
TUBA1A
|
Health Risk |
Pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121241333 |
TUBA1A
|
Health Risk |
Likely pathogenic |
— |
| RS2121241553 |
TUBA1A
|
Health Risk |
Pathogenic |
— |
| RS2121242709 |
TUBA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tubulinopathy-associated dysgyria, Tubulinopathy-associated dysgyria |
| RS2121242769 |
TUBA1A
|
Health Risk |
Likely pathogenic |
— |
| RS2121243281 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Seizure, Seizure |
| RS2121243396 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121243526 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS2121244045 |
TUBA1A
|
Health Risk |
Pathogenic |
West syndrome, Tubulinopathy-associated dysgyria |
| RS2121244201 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121244334 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121244360 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2121244643 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121244807 |
TUBA1A
|
Health Risk |
Likely pathogenic |
— |
| RS2121244979 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121245032 |
TUBA1A
|
Health Risk |
Pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121246284 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to LIS1 mutation |
| RS2121246309 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121246535 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Abnormal brain morphology, Abnormal brain morphology |
| RS2121247772 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
TUBA1A-associated tubulinopathy, TUBA1A-associated tubulinopathy |
| RS2121247899 |
TUBA1A
|
Health Risk |
Likely pathogenic |
— |
| RS2121248103 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121248568 |
TUBA1A
|
Health Risk |
Pathogenic |
Cerebral palsy, Cerebral palsy |
| RS2121248621 |
TUBA1A
|
Health Risk |
Likely pathogenic |
— |
| RS2121256921 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Lissencephaly due to TUBA1A mutation, Lissencephaly due to TUBA1A mutation |
| RS2121280782 |
PTPRQ
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 84A, Autosomal recessive nonsyndromic hearing loss 84A |
| RS2121304960 |
PTPRQ
|
Health Risk |
Likely pathogenic |
Ear malformation, Ear malformation |
| RS2121515547 |
PDE3A
|
Health Risk |
Likely pathogenic |
— |
| RS2122051585 |
DOHH
|
Health Risk |
Pathogenic |
DOHH related neurodevelopmental disorder, Neurodevelopmental disorder with microcephaly |
| RS2122122610 |
BCKDHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS2122122667 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |